Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yan Wang, Jun Li, Yuan-yuan Ren, Hong Zhao

Clin Mol Hepatol. 2013;19(4):382-388. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.382

View: 11031 Download: 86 Crossref: 18

Jung Mi Kim , Byung Ho Choe , Mi Ae Chu , Seung Man Cho

Clin Mol Hepatol. 2009;15(2):168-178. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.168

View: 4371 Download: 41 Crossref: 3

Jung Ho Seo, M.D.

Clin Mol Hepatol. 2003;9(4):304-314. Published online January 1, 1970

View: 2560 Download: 21

Jae Myung Lee , Jong Min Lee , Heui Seung Yoo , Ung Ki Jang , Dong Jun Kim , Yong Bum Kim , Hak Yang Kim , Choong Kee Park , Jae Young Yoo

Clin Mol Hepatol. 1996;2(2):160-165.

View: 2033 Download: 13

1 |

Viewed By 5820	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5129	MAFLD: How is it different from NAFLD?
Viewed By 4864	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3957	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3942	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 136	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 71	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 61	MAFLD: How is it different from NAFLD?

Search